The 5′UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs

E. Rulli, Federica Guffanti, Elisa Caiola, M. Ganzinelli, G. Damia, M.C. Garassino, Sheila Piva, Lorenzo Ceppi, M. Broggini, M. Marabese

Research output: Contribution to journalArticlepeer-review

Cite this